AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manzella, D.
Right arrow Articles by Paolisso, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manzella, D.
Right arrow Articles by Paolisso, G.
Agricola
Right arrow Articles by Manzella, D.
Right arrow Articles by Paolisso, G.
American Journal of Clinical Nutrition, Vol. 73, No. 6, 1052-1057, June 2001
© 2001 American Society for Clinical Nutrition


Original Research Communication

Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes1,2,3

Daniela Manzella, Michelangela Barbieri, Emilia Ragno and Giuseppe Paolisso

1 From the Department of Geriatric Medicine and Metabolic Diseases, Second University of Naples.

Background: Type 2 diabetes is associated with elevated oxidative stress and declines in antioxidant defense. The disease is also characterized by an imbalance in the ratio of cardiac sympathetic to parasympathetic tone. Antioxidants, vitamin E in particular, may have beneficial effects on the cardiac autonomic nervous system through a decline in oxidative stress.

Objective: We investigated the possible effects of vitamin E on the cardiac autonomic nervous system, as assessed by analysis of heart rate variability, in patients with type 2 diabetes and cardiac autonomic neuropathy.

Design: In a double-blind randomized controlled trial, 50 patients with type 2 diabetes were assigned to treatment with vitamin E (600 mg/d) or placebo for 4 mo.

Results: The anthropometric characteristics of the patients remained unchanged throughout the study. Chronic vitamin E administration was associated with decreases in concentrations of glycated hemoglobin (P < 0.05), plasma insulin (P < 0.05), norepinephrine (P < 0.03), and epinephrine (P < 0.02); a lower homeostasis model assessment index (P < 0.05); and improved indexes of oxidative stress. Furthermore, vitamin E administration was associated with increases in the R-R interval (P < 0.05), total power (P < 0.05), and the high-frequency component of heart rate variability (HF; P < 0.05) and decreases in the low-frequency component (LF; P < 0.05) and the ratio of LF to HF (P < 0.05). Finally, change in the plasma vitamin E concentration was correlated with change in the LF-HF ratio (r = -0.43, P < 0.04) independently of changes in the homeostasis model assessment index and plasma catecholamines concentrations.

Conclusions: Chronic vitamin E administration improves the ratio of cardiac sympathetic to parasympathetic tone in patients with type 2 diabetes. Such an effect might be mediated by a decline in oxidative stress.

Key Words: Vitamin E • heart rate variability • catecholamines • oxidative stress • type 2 diabetes • randomized controlled trial




This article has been cited by other articles:


Home page
DiabetesHome page
S. Liu, I-M. Lee, Y. Song, M. Van Denburgh, N. R. Cook, J. E. Manson, and J. E. Buring
Vitamin E and Risk of Type 2 Diabetes in the Women's Health Study Randomized Controlled Trial.
Diabetes, October 1, 2006; 55(10): 2856 - 2862.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
A. Ble, A. Cherubini, S. Volpato, B. Bartali, J. D. Walston, B. G. Windham, S. Bandinelli, F. Lauretani, J. M. Guralnik, and L. Ferrucci
Lower Plasma Vitamin E Levels Are Associated With the Frailty Syndrome: The InCHIANTI Study.
J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2006; 61(3): 278 - 283.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. E. Maser and M. J. Lenhard
Cardiovascular Autonomic Neuropathy Due to Diabetes Mellitus: Clinical Manifestations, Consequences, and Treatment
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5896 - 5903.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
Z. Y. Fang, J. B. Prins, and T. H. Marwick
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
Endocr. Rev., August 1, 2004; 25(4): 543 - 567.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
K. F. Harris and K. A. Matthews
Interactions Between Autonomic Nervous System Activity and Endothelial Function: A Model for the Development of Cardiovascular Disease
Psychosom Med, March 1, 2004; 66(2): 153 - 164.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. I. Vinik, R. E. Maser, B. D. Mitchell, and R. Freeman
Diabetic Autonomic Neuropathy
Diabetes Care, May 1, 2003; 26(5): 1553 - 1579.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. D. Hoeldtke, K. D. Bryner, D. R. McNeill, G. R. Hobbs, J. E. Riggs, S. S. Warehime, I. Christie, G. Ganser, and K. Van Dyke
Nitrosative Stress, Uric Acid, and Peripheral Nerve Function in Early Type 1 Diabetes
Diabetes, September 1, 2002; 51(9): 2817 - 2825.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by The American Society for Nutrition